Xeno Transplants Corporation (XENO)

Market Cap	4.04K +0.0%
Revenue (ttm)	n/a
Net Income	-256.37K
EPS	n/a
Shares Out	40.36M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0001
Beta	-34.36
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Xeno Transplants

Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from oth...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: XENO

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 19, 2026

Data Sources Report a data error